图书馆订阅: Guest
神经生物学评论综述™

每年出版 3 

ISSN 打印: 0892-0915

ISSN 在线: 2375-0014

SJR: 0.121

Impairment of GABAergic Transmission in Depression: New Insights from Neuroimaging Studies

卷 14, 册 1, 2000, 23 pages
DOI: 10.1615/CritRevNeurobiol.v14.i1.20
Get accessGet access

摘要

Several lines of evidence suggest that abnormalities in GABAergic neurotransmission are associated with the neurobiology of depression. Animal studies demonstrate that GABA agonists and antagonists can modulate commonly used behavioral models of depression and that chronic administration of antidepressant drugs induce marked changes in GABAergic function. In humans, depressed patients have lower plasma and CSF GABA concentrations than nondepressed comparison subjects. The recent discovery that several anticonvulsant and GABA-mimetic agents possess mood stabilizing and antidepressant properties has further increased interest in these findings. Novel imaging techniques now allow investigation of the GABAergic contribution to affective disorder pathophysiology. Through the techniques of PET, SPECT, and MRS, GABAergic function can be evaluated in vivo. Preliminary studies employing these techniques are finding new evidence suggesting that GABAergic abnormalities are associated with stress, anxiety, and depression. This article reviews the existing literature investigating the possible involvement of GABA in the neurobiology of depression and briefly highlights how these novel neuroimaging techniques can be used to further assess this hypothesis.

对本文的引用
  1. Lussier A.L., Romay-Tallón R., Caruncho H.J., Kalynchuk L.E., Altered GABAergic and glutamatergic activity within the rat hippocampus and amygdala in rats subjected to repeated corticosterone administration but not restraint stress, Neuroscience, 231, 2013. Crossref

  2. Ahern Todd H, Javors Martin A, Eagles Douglas A, Martillotti Jared, Mitchell Heather A, Liles Larry Cameron, Weinshenker David, The Effects of Chronic Norepinephrine Transporter Inactivation on Seizure Susceptibility in Mice, Neuropsychopharmacology, 31, 4, 2006. Crossref

  3. Barr Mera S., Farzan Faranak, Rajji Tarek K., Voineskos Aristotle N., Blumberger Daniel M., Arenovich Tamara, Fitzgerald Paul B., Daskalakis Zafiris J., Can Repetitive Magnetic Stimulation Improve Cognition in Schizophrenia? Pilot Data from a Randomized Controlled Trial, Biological Psychiatry, 73, 6, 2013. Crossref

  4. Bajbouj Malek, Gallinat Jurgen, Lang Undine E., Neu Peter, Niehaus Ludwig, Chapter 43 Motorcortical excitability after electroconvulsive therapy in patients with major depressive disorder, in Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation, Proceedings of the 2nd International Transcranial Magnetic Stimulation (TMS) and Transcranial Direct Current Stimulation (tDCS) Symposium, 56, 2003. Crossref

  5. Rajkowska Grazyna, O'Dwyer Gillian, Teleki Zsofia, Stockmeier Craig A, Miguel-Hidalgo Jose Javier, GABAergic Neurons Immunoreactive for Calcium Binding Proteins are Reduced in the Prefrontal Cortex in Major Depression, Neuropsychopharmacology, 32, 2, 2007. Crossref

  6. Zimmer Geraldine, Schanuel Sheine M., Bürger Susanne, Weth Franco, Steinecke André, Bolz Jürgen, Lent Roberto, Chondroitin Sulfate Acts in Concert with Semaphorin 3A to Guide Tangential Migration of Cortical Interneurons in the Ventral Telencephalon, Cerebral Cortex, 20, 10, 2010. Crossref

  7. Wisłowska-Stanek Aleksandra, Lehner Małgorzata, Skórzewska Anna, Krząścik Paweł, Maciejak Piotr, Szyndler Janusz, Ziemba Andrzej, Płaźnik Adam, Changes in the brain expression of alpha-2 subunits of the GABA-A receptor after chronic restraint stress in low- and high-anxiety rats, Behavioural Brain Research, 253, 2013. Crossref

  8. Muralidharan Anjana, Bhagwagar Zubin, Potential of Levetiracetam in Mood Disorders, CNS Drugs, 20, 12, 2006. Crossref

  9. Stettner Georg M., Rukhadze Irma, Mann Graziella L., Lei Yanlin, Kubin Leszek, Respiratory modulation of lingual muscle activity across sleep–wake states in rats, Respiratory Physiology & Neurobiology, 188, 3, 2013. Crossref

  10. Vitaliano Peter P., Zhang Jianping, Scanlan James M., Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis., Psychological Bulletin, 129, 6, 2003. Crossref

  11. Veeraiah Pandichelvam, Noronha Judith Miriam, Maitra Swati, Bagga Puneet, Khandelwal Nitin, Chakravarty Sumana, Kumar Arvind, Patel Anant B., Dysfunctional Glutamatergic and γ-Aminobutyric Acidergic Activities in Prefrontal Cortex of Mice in Social Defeat Model of Depression, Biological Psychiatry, 76, 3, 2014. Crossref

  12. Condren Rita M., Lucey Jim V., Thakore Jogin H., A preliminary study of baclofen-induced growth hormone release in generalised social phobia, Human Psychopharmacology: Clinical and Experimental, 18, 2, 2003. Crossref

  13. Whittemore Robin, Kanner Sheri, Singleton Sabrina, Hamrin Vanya, Chiu Joy, Grey Margaret, Correlates of depressive symptoms in adolescents with type 1 diabetes, Pediatric Diabetes, 3, 3, 2002. Crossref

  14. Kalueff Allan V., Nutt David J., Role of GABA in anxiety and depression, Depression and Anxiety, 24, 7, 2007. Crossref

  15. Möhler Hanns, The GABA system in anxiety and depression and its therapeutic potential, Neuropharmacology, 62, 1, 2012. Crossref

  16. Kendell Steven F, Krystal John H, Sanacora Gerrard, GABA and glutamate systems as therapeutic targets in depression and mood disorders, Expert Opinion on Therapeutic Targets, 9, 1, 2005. Crossref

  17. Zink M., Vollmayr B., Gebicke-Haerter P. J., Henn F. A., Reduced Expression of GABA Transporter GAT3 in Helpless Rats, an Animal Model of Depression, Neurochemical Research, 34, 9, 2009. Crossref

  18. Fukumoto Kenichi, Chaki Shigeyuki, Involvement of serotonergic system in the effect of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test, Journal of Pharmacological Sciences, 127, 1, 2015. Crossref

  19. Mancino Michael J., McGaugh Janette, Chopra Mohit P., Guise Joseph B., Cargile Christopher, Williams D. Keith, Thostenson Jeff, Kosten Thomas R., Sanders Nichole, Oliveto Alison, Clinical Efficacy of Sertraline Alone and Augmented With Gabapentin in Recently Abstinent Cocaine-Dependent Patients With Depressive Symptoms, Journal of Clinical Psychopharmacology, 34, 2, 2014. Crossref

  20. Krystal John H., State Matthew W., Psychiatric Disorders: Diagnosis to Therapy, Cell, 157, 1, 2014. Crossref

  21. Jinno Shozo, Kosaka Toshio, Neuronal circuit-dependent alterations in expression of two isoforms of glutamic acid decarboxylase in the hippocampus following electroconvulsive shock: A stereology-based study, Hippocampus, 19, 11, 2009. Crossref

  22. Zimmer Geraldine, Garcez Patricia, Rudolph Judith, Niehage Ronny, Weth Franco, Lent Roberto, Bolz Jürgen, Ephrin-A5 acts as a repulsive cue for migrating cortical interneurons, European Journal of Neuroscience, 28, 1, 2008. Crossref

  23. Marín O., López-Bendito G., Neuronal Migration, in Evolution of Nervous Systems, 2007. Crossref

  24. Sharpley Christopher F, Bitsika Vicki, Four potential criteria for deciding when to use antidepressants or psychotherapy for unipolar depression: A literature review, International Journal of Psychiatry in Clinical Practice, 15, 1, 2011. Crossref

  25. Schechter Lee E, Lin Qian, Smith Deborah L, Zhang Guoming, Shan Qin, Platt Brian, Brandt Michael R, Dawson Lee A, Cole Derek, Bernotas Ron, Robichaud Albert, Rosenzweig-Lipson Sharon, Beyer Chad E, Neuropharmacological Profile of Novel and Selective 5-HT6 Receptor Agonists: WAY-181187 and WAY-208466, Neuropsychopharmacology, 33, 6, 2008. Crossref

  26. SANACORA GERARD, ROTHMAN DOUGLAS L., MASON GRAEME, KRYSTAL JOHN H., Clinical Studies Implementing Glutamate Neurotransmission in Mood Disorders, Annals of the New York Academy of Sciences, 1003, 1, 2003. Crossref

  27. Wesołowska Anna, Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data, Pharmacological Reports, 62, 4, 2010. Crossref

  28. Lanni Cristina, Govoni Stefano, Lucchelli Adele, Boselli Cinzia, Depression and antidepressants: molecular and cellular aspects, Cellular and Molecular Life Sciences, 66, 18, 2009. Crossref

  29. Naegele Janice R., Trekking through the Telencephalon: Hepatocyte Growth Factor-Mediated Guidance for Parvalbumin-Expressing Interneurons, Epilepsy Currents, 10, 4, 2010. Crossref

  30. Gunn Benjamin G., Cunningham Linda, Mitchell Scott G., Swinny Jerome D., Lambert Jeremy J., Belelli Delia, GABAA receptor-acting neurosteroids: A role in the development and regulation of the stress response, Frontiers in Neuroendocrinology, 36, 2015. Crossref

  31. Ouellet Lydia, de Villers-Sidani Etienne, Trajectory of the main GABAergic interneuron populations from early development to old age in the rat primary auditory cortex, Frontiers in Neuroanatomy, 8, 2014. Crossref

  32. Vaiva Guillaume, Thomas Pierre, Ducrocq François, Fontaine Monique, Boss Virginie, Devos Patrick, Rascle Claire, Cottencin Olivier, Brunet Alain, Laffargue Philippe, Goudemand Michel, Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder, Biological Psychiatry, 55, 3, 2004. Crossref

  33. Feng Pingfu, Guan Zhiwei, Yang Xiaoping, Fang Jidong, Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine, Brain Research, 991, 1-2, 2003. Crossref

  34. Sharpley Christopher F., Antidepressants in counselling psychology: Relevance, effectiveness and implications for practice, Counselling Psychology Quarterly, 24, 2, 2011. Crossref

  35. Grey Margaret, Whittemore Robin, Tamborlane William, Depression in Type 1 diabetes in children, Journal of Psychosomatic Research, 53, 4, 2002. Crossref

  36. Wesołowska Anna, Jastrzębska-Więsek Magdalena, Behavioral Pharmacology: Potential Antidepressant and Anxiolytic Properties, in International Review of Neurobiology Volume 96, 96, 2011. Crossref

  37. He Dongye, Wang Xitao, Zhang Ping, Luo Xinxing, Li Xiaoyu, Wang Lili, Li Shuying, Xu Yongping, Evaluation of the Anxiolytic and Antidepressant Activities of the Aqueous Extract fromCamellia euphlebiaMerr. ex Sealy in Mice, Evidence-Based Complementary and Alternative Medicine, 2015, 2015. Crossref

  38. Sen Srijan, Villafuerte Sandra, Nesse Randolph, Stoltenberg Scott F, Hopcian Jeffrey, Gleiberman Lillian, Weder Alan, Burmeister Margit, Serotonin transporter and GABA(A) alpha 6 receptor variants are associated with neuroticism, Biological Psychiatry, 55, 3, 2004. Crossref

  39. Bhagwagar Zubin, Wylezinska Marzena, Jezzard Peter, Evans John, Ashworth Fiona, Sule Akeem, Matthews Paul M., Cowen Philip J., Reduction in Occipital Cortex γ-Aminobutyric Acid Concentrations in Medication-Free Recovered Unipolar Depressed and Bipolar Subjects, Biological Psychiatry, 61, 6, 2007. Crossref

  40. Kühn Simone, Schubert Florian, Mekle Ralf, Wenger Elisabeth, Ittermann Bernd, Lindenberger Ulman, Gallinat Jürgen, Neurotransmitter changes during interference task in anterior cingulate cortex: evidence from fMRI-guided functional MRS at 3 T, Brain Structure and Function, 221, 5, 2016. Crossref

  41. Yue Li, Xiao-lin Huo, Tao Song, The effects of chronic repetitive transcranial magnetic stimulation on glutamate and gamma-aminobutyric acid in rat brain, Brain Research, 1260, 2009. Crossref

  42. Iosifescu Dan V., van Nieuwenhuizen Adrienne O., Neuroimaging and Electrophysiology Studies in Major Depressive Disorder, in Depression, 2009. Crossref

  43. Vollenweider Isabel, Smith Kiersten S., Keist Ruth, Rudolph Uwe, Antidepressant-like properties of α2-containing GABAA receptors, Behavioural Brain Research, 217, 1, 2011. Crossref

  44. Stockmeier Craig A., Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter, Journal of Psychiatric Research, 37, 5, 2003. Crossref

  45. Nemmani K.V.S., Mogil J.S., Serotonin–GABA interactions in the modulation of mu- and kappa-opioid analgesia, Neuropharmacology, 44, 3, 2003. Crossref

  46. Reagan Lawrence P., Grillo Claudia A., Piroli Gerado G., The As and Ds of stress: Metabolic, morphological and behavioral consequences, European Journal of Pharmacology, 585, 1, 2008. Crossref

  47. Waddell Kevin W., Avison Malcolm J., Joers James M., Gore John C., A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil, Magnetic Resonance Imaging, 25, 7, 2007. Crossref

  48. Goto Naoki, Yoshimura Reiji, Moriya Junji, Kakeda Shingo, Hayashi Kenji, Ueda Nobuhisa, Ikenouchi-Sugita Atsuko, Umene-Nakano Wakako, Oonari Norihiro, Korogi Yukunori, Nakamura Jun, Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study, Psychiatry Research: Neuroimaging, 182, 1, 2010. Crossref

  49. Lymer Katherine, Haga Kristin, Marshall Ian, Sailasuta Napapon, Wardlaw Joanna, Reproducibility of GABA measurements using 2D J-resolved magnetic resonance spectroscopy, Magnetic Resonance Imaging, 25, 5, 2007. Crossref

  50. Ghose Subroto, Winter Michelle K, McCarson Kenneth E, Tamminga Carol A, Enna Salvatore J, The GABAB receptor as a target for antidepressant drug action, British Journal of Pharmacology, 162, 1, 2011. Crossref

  51. Xing Bo, Zhao Yan, Zhang Hui, Dang Yonghui, Chen Teng, Huang Jingfeng, Luo Qi, Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antidepressant-like effect in the rat forced swim test, Brain Research Bulletin, 85, 3-4, 2011. Crossref

  52. Nestler Eric J., Gould Elizabeth, Manji Husseini, Preclinical models: status of basic research in depression, Biological Psychiatry, 52, 6, 2002. Crossref

  53. Reichel Judith M., Nissel Sabine, Rogel-Salazar Gabriela, Mederer Anna, Käfer Karola, Bedenk Benedikt T., Martens Henrik, Anders Rebecca, Grosche Jens, Michalski Dominik, Härtig Wolfgang, Wotjak Carsten T., Distinct behavioral consequences of short-term and prolonged GABAergic depletion in prefrontal cortex and dorsal hippocampus, Frontiers in Behavioral Neuroscience, 8, 2015. Crossref

  54. Chudal Roshan, Sourander Andre, Surcel Heljä-Marja, Sucksdorff Dan, Hinkka-Yli-Salomäki Susanna, Brown Alan S., Gestational maternal C-­reactive protein and risk of bipolar disorder among young individuals in a Nationwide Birth Cohort, Journal of Affective Disorders, 208, 2017. Crossref

  55. Felice Daniela, O’Leary Olivia F., Cryan John F., Targeting the GABAB Receptor for the Treatment of Depression and Anxiety Disorders, in GABAB Receptor, 2016. Crossref

  56. Pesarico Ana Paula, Stangherlin Eluza Curte, Rosa Suzan Gonçalves, Mantovani Anderson C., Zeni Gilson, Nogueira Cristina Wayne, Contribution of NMDA, GABAA and GABAB receptors and l-arginine-NO-cGMP, MEK1/2 and CaMK-II pathways in the antidepressant-like effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in mice, European Journal of Pharmacology, 782, 2016. Crossref

  57. Sharpley Christopher F., Bitsika Vicki, Is Depression “Evolutionary” or Just “Adaptive”? A Comment, Depression Research and Treatment, 2010, 2010. Crossref

  58. Pochwat Bartłomiej, Nowak Gabriel, Szewczyk Bernadeta, Brain glutamic acid decarboxylase-67kDa alterations induced by magnesium treatment in olfactory bulbectomy and chronic mild stress models in rats, Pharmacological Reports, 68, 5, 2016. Crossref

  59. Kugaya Akira, Sanacora Gerard, Beyond Monoamines: Glutamatergic Function in Mood Disorders, CNS Spectrums, 10, 10, 2005. Crossref

  60. Yarom Orli, Maroun Mouna, Richter-Levin Gal, Exposure to Forced Swim Stress Alters Local Circuit Activity and Plasticity in the Dentate Gyrus of the Hippocampus, Neural Plasticity, 2008, 2008. Crossref

  61. Nazari Seyedeh Khadijeh, Nikoui Vahid, Ostadhadi Sattar, Chegini Zahra Hadi, Oryan Shahrbanoo, Bakhtiarian Azam, Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effect of baclofen in mouse forced swimming test, Pharmacological Reports, 68, 6, 2016. Crossref

  62. Lehmann Konrad, Steinecke André, Bolz Jürgen, GABA through the Ages: Regulation of Cortical Function and Plasticity by Inhibitory Interneurons, Neural Plasticity, 2012, 2012. Crossref

  63. Gupta Deepali, Prabhakar Visakh, Radhakrishnan Mahesh, 5HT3 receptors: Target for new antidepressant drugs, Neuroscience & Biobehavioral Reviews, 64, 2016. Crossref

  64. Freed Rachel D., Hollenhorst Cecilia N., Weiduschat Nora, Mao Xiangling, Kang Guoxin, Shungu Dikoma C., Gabbay Vilma, A pilot study of cortical glutathione in youth with depression, Psychiatry Research: Neuroimaging, 270, 2017. Crossref

  65. Rajkowska Grazyna, Depression: What We can Learn from Postmortem Studies, The Neuroscientist, 9, 4, 2003. Crossref

  66. Sharpley Christopher F, Malfunction in GABA and Glutamate as Pathways to Depression: A Review of the Evidence, Clinical Medicine. Therapeutics, 1, 2009. Crossref

  67. Cavalcante Giuliana Ignácio Teixeira, Chaves Filho Adriano José Maia, Linhares Maria Isabel, de Carvalho Lima Camila Nayane, Venâncio Edith Teles, Rios Emiliano Ricardo Vasconcelos, de Souza Francisca Cléa Florenço, Vasconcelos Silvânia Maria Mendes, Macêdo Danielle, de França Fonteles Marta Maria, HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum, European Journal of Pharmacology, 799, 2017. Crossref

  68. Ostadhadi Sattar, Akbarian Reyhaneh, Norouzi-Javidan Abbas, Nikoui Vahid, Zolfaghari Samira, Chamanara Mohsen, Dehpour Ahmad-Reza, Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effects of gabapentin in mouse forced swimming test, Canadian Journal of Physiology and Pharmacology, 95, 7, 2017. Crossref

  69. Kosel Markus, Rudolph Uwe, Wielepp Peter, Luginbühl Martin, Schmitt Wolfgang, Fisch Hans U, Schlaepfer Thomas E, Diminished GABAA Receptor-Binding Capacity and a DNA Base Substitution in a Patient with Treatment-Resistant Depression and Anxiety, Neuropsychopharmacology, 29, 2, 2004. Crossref

  70. Otsuka Takeshi, Kawaguchi Yasuo, Common excitatory synaptic inputs to electrically connected cortical fast-spiking cell networks, Journal of Neurophysiology, 110, 4, 2013. Crossref

  71. Li Suyan, Kumar T Peeyush, Joshee Sampada, Kirschstein Timo, Subburaju Sivan, Khalili Jahan S, Kloepper Jonas, Du Chuang, Elkhal Abdallah, Szabó Gábor, Jain Rakesh K, Köhling Rüdiger, Vasudevan Anju, Endothelial cell-derived GABA signaling modulates neuronal migration and postnatal behavior, Cell Research, 28, 2, 2018. Crossref

  72. Stanley Jeffrey A, In vivo Magnetic Resonance Spectroscopy and its Application to Neuropsychiatric Disorders, The Canadian Journal of Psychiatry, 47, 4, 2002. Crossref

  73. Wang Guo-Li, Wang Ying-Ping, Zheng Jing-Yu, Zhang Lian-Xue, Monoaminergic and aminoacidergic receptors are involved in the antidepressant-like effect of ginsenoside Rb1 in mouse hippocampus (CA3) and prefrontal cortex, Brain Research, 1699, 2018. Crossref

  74. Ries Anja, Chang Catie, Glim Sarah, Meng Chun, Sorg Christian, Wohlschläger Afra, Grading of Frequency Spectral Centroid Across Resting-State Networks, Frontiers in Human Neuroscience, 12, 2018. Crossref

  75. Lukkes Jodi L., Meda Shirisha, Norman Kevin J., Andersen Susan L., Anhedonic behavior and γ-amino butyric acid during a sensitive period in female rats exposed to early adversity, Journal of Psychiatric Research, 100, 2018. Crossref

  76. Ghasemi Maedeh, Mehranfard Nasrin, Mechanisms underlying anticonvulsant and proconvulsant actions of norepinephrine, Neuropharmacology, 137, 2018. Crossref

  77. Chávez-Castillo Mervin, Núñez Victoria, Nava Manuel, Ortega Ángel, Rojas Milagros, Bermúdez Valmore, Rojas-Quintero Joselyn, Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines, Advances in Pharmacological Sciences, 2019, 2019. Crossref

  78. Choi Yong Kee, Vasudevan Anju, Mechanistic insights into autocrine and paracrine roles of endothelial GABA signaling in the embryonic forebrain, Scientific Reports, 9, 1, 2019. Crossref

  79. Newton Dwight F., Fee Corey, Nikolova Yuliya S., Sibille Etienne, Altered GABAergic Function, Cortical Microcircuitry, and Information Processing in Depression, in Neurobiology of Depression, 2019. Crossref

  80. Cohen Ronald A., Psychiatric Disturbances of Attention, in The Neuropsychology of Attention, 2014. Crossref

  81. Taylor Chirisse, Fricker Ashwana D., Devi Lakshmi A., Gomes Ivone, Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways, Cellular Signalling, 17, 5, 2005. Crossref

  82. Sharpley Christopher F., Agnew Linda L., Cytokines and depression: findings, issues, and treatment implications, revneuro, 22, 3, 2011. Crossref

  83. Taylor Stephan F, Grove Tyler B, Ellingrod Vicki L, Tso Ivy F, The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis, Schizophrenia Bulletin, 45, 6, 2019. Crossref

  84. Amidfar Meysam, Woelfer Marie, Réus Gislaine Z., Quevedo João, Walter Martin, Kim Yong-Ku, The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 94, 2019. Crossref

  85. Wang Zan, Shi Yanmin, Liu Fangfang, Jia Nan, Gao Junya, Pang Xiaomin, Deng Fang, Diversiform Etiologies for Post-stroke Depression, Frontiers in Psychiatry, 9, 2019. Crossref

  86. Tsang Shui Y., Ullah Ata, Xue Hong, GABRB2 in Neuropsychiatric Disorders: Genetic Associations and Functional Evidences, Current Psychopharmacology, 8, 3, 2019. Crossref

  87. Ye Eunbi, Lee Sooyeon, Park Wonbin, Park Eunkyoung, Cho Dong-Woo, Jang Jinah, Park Sung-Min, In Vitro Study of Neurochemical Changes Following Low-Intensity Magnetic Stimulation, IEEE Access, 8, 2020. Crossref

  88. Linde Jenice, Zimmer-Bensch Geraldine, DNA Methylation-Dependent Dysregulation of GABAergic Interneuron Functionality in Neuropsychiatric Diseases, Frontiers in Neuroscience, 14, 2020. Crossref

  89. Câmara Alice Barros, Brandão Igor Augusto, Neural Receptors Associated with Depression: A Systematic Review of the Past 10 Years, CNS & Neurological Disorders - Drug Targets , 19, 6, 2020. Crossref

  90. Mathew Jobin, Balakrishnan Savitha, Antony Sherin, Abraham Pretty Mary, Paulose CS, Decreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-A, Journal of Biomedical Science, 19, 1, 2012. Crossref

  91. Wang Shujing, Deng Ziteng, Wang Jia, Zhang Wenjun, Liu Fenghua, Xu Jianqin, Ma Yunfei, Decreased GABAergic signaling, fewer parvalbumin-, somatostatin- and calretinin-positive neurons in brain of a rat model of simulated transport stress, Research in Veterinary Science, 134, 2021. Crossref

  92. Fatih Parmis, Kucuker M. Utku, Vande Voort Jennifer L., Doruk Camsari Deniz, Farzan Faranak, Croarkin Paul E., A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders, Frontiers in Psychiatry, 12, 2021. Crossref

  93. Zorumski Charles F., Paul Steven M., Izumi Yukitoshi, Covey Douglas F., Mennerick Steven, Neurosteroids, stress and depression: Potential therapeutic opportunities, Neuroscience & Biobehavioral Reviews, 37, 1, 2013. Crossref

  94. Ironside Maria, Moser Amelia D., Holsen Laura M., Zuo Chun S., Du Fei, Perlo Sarah, Richards Christine E., Duda Jessica M., Chen Xi, Nickerson Lisa D., Null Kaylee E., Nascimento Nara, Crowley David J., Misra Madhusmita, Goldstein Jill M., Pizzagalli Diego A., Reductions in rostral anterior cingulate GABA are associated with stress circuitry in females with major depression: a multimodal imaging investigation, Neuropsychopharmacology, 46, 12, 2021. Crossref

  95. Steinecke André, Gampe Christin, Zimmer Geraldine, Rudolph Judith, Bolz Jürgen, EphA/ephrin A reverse signaling promotes the migration of cortical interneurons from the medial ganglionic eminence, Development, 141, 2, 2014. Crossref

  96. Wang Wei, Guo Hua, Zhang Shu-Xiao, Li Juan, Cheng Ke, Bai Shun-Jie, Yang De-Yu, Wang Hai-Yang, Liang Zi-Hong, Liao Li, Sun Lin, Xie Peng, Targeted Metabolomic Pathway Analysis and Validation Revealed Glutamatergic Disorder in the Prefrontal Cortex among the Chronic Social Defeat Stress Mice Model of Depression, Journal of Proteome Research, 15, 10, 2016. Crossref

  97. Fan Xiaotang, Warner Margaret, Gustafsson Jan-Åke, Estrogen receptor β expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons, Proceedings of the National Academy of Sciences, 103, 51, 2006. Crossref

  98. Port John D., Puri Basant K., Magnetic resonance spectroscopy in psychiatry, in Clinical MR Neuroimaging, 2009. Crossref

  99. Krystal J H, Sanacora G, Blumberg H, Anand A, Charney D S, Marek G, Epperson C N, Goddard A, Mason G F, Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments, Molecular Psychiatry, 7, S1, 2002. Crossref

  100. Ciavarelli Ambra, Contemori Giulio, Battaglini Luca, Barollo Michele, Casco Clara, Dyslexia and the magnocellular-parvocellular coactivaton hypothesis, Vision Research, 179, 2021. Crossref

  101. Liaci Carla, Camera Mattia, Zamboni Valentina, Sarò Gabriella, Ammoni Alessandra, Parmigiani Elena, Ponzoni Luisa, Hidisoglu Enis, Chiantia Giuseppe, Marcantoni Andrea, Giustetto Maurizio, Tomagra Giulia, Carabelli Valentina, Torelli Federico, Sala Mariaelvina, Yanagawa Yuchio, Obata Kunihiko, Hirsch Emilio, Merlo Giorgio R., Loss of ARHGAP15 affects the directional control of migrating interneurons in the embryonic cortex and increases susceptibility to epilepsy, Frontiers in Cell and Developmental Biology, 10, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain